These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 15683610)
21. Spotlight on omalizumab in allergic asthma. Bang LM; Plosker GL BioDrugs; 2004; 18(6):415-8. PubMed ID: 15571425 [TBL] [Abstract][Full Text] [Related]
22. Omalizumab: a review of its use in the management of allergic asthma. Bang LM; Plosker GL Treat Respir Med; 2004; 3(3):183-99. PubMed ID: 15219177 [TBL] [Abstract][Full Text] [Related]
24. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888 [TBL] [Abstract][Full Text] [Related]
25. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. Casale TB; Condemi J; LaForce C; Nayak A; Rowe M; Watrous M; McAlary M; Fowler-Taylor A; Racine A; Gupta N; Fick R; Della Cioppa G; JAMA; 2001 Dec; 286(23):2956-67. PubMed ID: 11743836 [TBL] [Abstract][Full Text] [Related]
26. Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis. Chervinsky P; Casale T; Townley R; Tripathy I; Hedgecock S; Fowler-Taylor A; Shen H; Fox H Ann Allergy Asthma Immunol; 2003 Aug; 91(2):160-7. PubMed ID: 12952110 [TBL] [Abstract][Full Text] [Related]
27. Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma. Ruffin CG; Busch BE Am J Health Syst Pharm; 2004 Jul; 61(14):1449-59. PubMed ID: 15332692 [TBL] [Abstract][Full Text] [Related]
28. Omalizumab: efficacy in allergic disease. Spector S Panminerva Med; 2004 Jun; 46(2):141-8. PubMed ID: 15507883 [TBL] [Abstract][Full Text] [Related]
29. Omalizumab: where does it fit into current asthma management? Rambasek TE; Lang DM; Kavuru MS Cleve Clin J Med; 2004 Mar; 71(3):251-61. PubMed ID: 15055248 [TBL] [Abstract][Full Text] [Related]
30. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab. Nowak D Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266 [TBL] [Abstract][Full Text] [Related]
32. Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection. Cruz AA; Lima F; Sarinho E; Ayre G; Martin C; Fox H; Cooper PJ Clin Exp Allergy; 2007 Feb; 37(2):197-207. PubMed ID: 17250692 [TBL] [Abstract][Full Text] [Related]
33. Omalizumab: a review of its use in the treatment of allergic asthma. Plosker GL; Keam SJ BioDrugs; 2008; 22(3):189-204. PubMed ID: 18481901 [TBL] [Abstract][Full Text] [Related]
35. Newer aspects in the treatment of pediatric and adult asthma: monoclonal anti-IgE. Lanier BQ Ann Allergy Asthma Immunol; 2003 Jun; 90(6 Suppl 3):13-5. PubMed ID: 12839107 [TBL] [Abstract][Full Text] [Related]
36. The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update. Holgate S; Buhl R; Bousquet J; Smith N; Panahloo Z; Jimenez P Respir Med; 2009 Aug; 103(8):1098-113. PubMed ID: 19362459 [TBL] [Abstract][Full Text] [Related]
37. [Anti-immunoglobulin E, a monoclonal antibody to treat respiratory disorders]. Cabrera-Navarro P Arch Bronconeumol; 2006 May; 42(5):241-5. PubMed ID: 16740240 [TBL] [Abstract][Full Text] [Related]
38. Anti-IgE monoclonal antibody, omalizumab: a new treatment for allergic asthma. Chung KF Expert Opin Pharmacother; 2004 Feb; 5(2):439-46. PubMed ID: 14996639 [TBL] [Abstract][Full Text] [Related]
39. [Omalizumab in severe asthma--case report]. Gawlewicz-Mroczka A; Nizankowska-Mogilnicka E Pol Arch Med Wewn; 2006 Aug; 116(2):766-70. PubMed ID: 17424922 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of omalizumab from a health plan perspective. Belliveau PP; Lahoz MR J Manag Care Pharm; 2005; 11(9):735-45. PubMed ID: 16300417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]